{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]P40337,1,P40337,170,5]["},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P40337","source":"P40337|von Hippel-Lindau disease tumor suppressor","targets":["1LM8|Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex|X-RAY DIFFRACTION|1.85|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1LQB|Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B complex|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|GENE REGULATION","1VCB|THE VHL-ELONGINC-ELONGINB STRUCTURE|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSCRIPTION","3ZRC|pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL)BENZYL]-L-PROLINAMIDE bound|X-RAY DIFFRACTION|2.9|HOMO SAPIENS|0|TRANSCRIPTION","3ZRF|pVHL54-213-EloB-EloC complex_apo|X-RAY DIFFRACTION|2.8|HOMO SAPIENS|0|TRANSCRIPTION","3ZTC|pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisoxazol-5-yl)acetyl)pyrrolidine-2- carboxamide|X-RAY DIFFRACTION|2.65|HOMO SAPIENS|0|TRANSCRIPTION","3ZTD|pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyrrolidine-2-carboxamido)methyl)benzoate|X-RAY DIFFRACTION|2.79|HOMO SAPIENS|0|TRANSCRIPTION","3ZUN|pVHL54-213-EloB-EloC complex_(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol- 5-yl)acetyl)-N-(4-nitrobenzyl)pyrrolidine-2-carboxamide bound|X-RAY DIFFRACTION|2.5|HOMO SAPIENS|0|TRANSCRIPTION","4AJY|von Hippel-Lindau protein-ElonginB-ElonginC complex, bound to Hif1- alpha peptide|X-RAY DIFFRACTION|1.73|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4AWJ|pVHL:EloB:EloC complex, in complex with capped Hydroxyproline|X-RAY DIFFRACTION|2.5|HOMO SAPIENS|0|TRANSCRIPTION","4B95|pVHL-EloB-EloB-EloC complex_(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidanyl-pyrrolidine-2-carboxamide bound|X-RAY DIFFRACTION|2.8|HOMO SAPIENS|0|TRANSCRIPTION","4B9K|pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide bound|X-RAY DIFFRACTION|2|HOMO SAPIENS|0|LIGASE","4BKS|von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-oxazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide|X-RAY DIFFRACTION|2.2|HOMO SAPIENS|0|PROTEIN TRANSPORT","4BKT|von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methyl-1,2-oxazol-5-yl)ethanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide|X-RAY DIFFRACTION|2.35|HOMO SAPIENS|0|PROTEIN TRANSPORT","4W9C|pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 2)|X-RAY DIFFRACTION|2.2|Homo sapiens|0|LIGASE","4W9D|pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methyloxazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 3)|X-RAY DIFFRACTION|2.2|Homo sapiens|0|LIGASE","4W9E|pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 4)|X-RAY DIFFRACTION|2.6|Homo sapiens|0|LIGASE","4W9F|pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 5)|X-RAY DIFFRACTION|2.1|Homo sapiens|0|LIGASE","4W9G|pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(3-methyl-4-(thiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 6)|X-RAY DIFFRACTION|2.7|Homo sapiens|0|LIGASE","4W9H|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 7)|X-RAY DIFFRACTION|2.1|Homo sapiens|0|LIGASE","4W9I|pVHL:EloB:EloC in complex with (2S,4R)-1-((2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carbonyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 10)|X-RAY DIFFRACTION|2.4|Homo sapiens|0|LIGASE","4W9J|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 13)|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSCRIPTION","4W9K|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 14)|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","4W9L|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3,3-dimethylbutanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 15)|X-RAY DIFFRACTION|2.2|Homo sapiens|0|LIGASE","4WQO|Structure of VHL-EloB-EloC-Cul2|X-RAY DIFFRACTION|3.2|Homo sapiens|0|TRANSCRIPTION","5LLI|pVHL:EloB:EloC in complex with VH298|X-RAY DIFFRACTION|2.4|Homo sapiens|0|LIGASE","5N4W|Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex|X-RAY DIFFRACTION|3.9|Homo sapiens|0|LIGASE","5NVV|pVHL:EloB:EloC in complex with (2S,4R)-4-hydroxy-1-((S)-2-(2-hydroxyacetamido)-3,3-dimethylbutanoyl)-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 3)|X-RAY DIFFRACTION|2.1|Homo sapiens|0|LIGASE","5NVW|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 6)|X-RAY DIFFRACTION|2.2|Homo sapiens|0|LIGASE","5NVX|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-fluorocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 10)|X-RAY DIFFRACTION|2.2|Homo sapiens|0|LIGASE","5NVY|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamidopropanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl) pyrrolidine-2-carboxamide (ligand 11)|X-RAY DIFFRACTION|2.9|Homo sapiens|0|LIGASE","5NVZ|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 16)|X-RAY DIFFRACTION|2.7|Homo sapiens|0|LIGASE","5NW0|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetamidocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 17)|X-RAY DIFFRACTION|2.3|Homo sapiens|0|LIGASE","5NW1|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 18)|X-RAY DIFFRACTION|2.1|Homo sapiens|0|LIGASE","5NW2|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-3,3-dimethyl-2-(oxetane-3-carboxamido)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 19)|X-RAY DIFFRACTION|2.2|Homo sapiens|0|LIGASE","5T35|The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.7|Homo sapiens|0|LIGASE","6BVB|Crystal structure of HIF-2alpha-pVHL-elongin B-elongin C|X-RAY DIFFRACTION|2.002|Homo sapiens; SYNTHETIC CONSTRUCT|0|GENE REGULATION","6FMI|pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamothioyl) pyrrolidin-1-yl)-1-oxopropan-2-yl)acetamide (ligand 2)|X-RAY DIFFRACTION|2.8|Homo sapiens|0|LIGASE","6FMJ|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl) benzyl)pyrrolidine-2-carboxamide (ligand 3)|X-RAY DIFFRACTION|2.45|Homo sapiens|0|LIGASE","6FMK|pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamothioyl) pyrrolidin-1-yl)-1-thioxopropan-2-yl)acetamide (ligand 4)|X-RAY DIFFRACTION|2.75|Homo sapiens|0|LIGASE","6GFX|pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand 13a)|X-RAY DIFFRACTION|1.83|Homo sapiens; SYNTHETIC CONSTRUCT|0|LIGASE","6GFY|pVHL:EloB:EloC in complex with modified VH032 containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand 14a)|X-RAY DIFFRACTION|2.7|Homo sapiens|0|LIGASE","6GFZ|pVHL:EloB:EloC in complex with modified VH032 containing (3S,4S)-3-fluoro-4-hydroxyproline (ligand 14b)|X-RAY DIFFRACTION|2.3|Homo sapiens|0|LIGASE","6GMN|pVHL:EloB:EloC in complex with methyl 4H-furo[3,2-b]pyrrole-5-carboxylate|X-RAY DIFFRACTION|1.94|Homo sapiens|0|ONCOPROTEIN","6GMQ|pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol|X-RAY DIFFRACTION|2.755|Homo sapiens|0|ONCOPROTEIN","6GMR|pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol|X-RAY DIFFRACTION|1.75|Homo sapiens; SYNTHETIC CONSTRUCT|0|LIGASE","6GMX|pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one|X-RAY DIFFRACTION|2.533|Homo sapiens|0|ONCOPROTEIN","6HAX|Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.35|Homo sapiens|0|GENE REGULATION","6HAY|Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.24|Homo sapiens|0|GENE REGULATION","6HR2|Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|1.76|Homo sapiens|0|TRANSCRIPTION","6I7Q|Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in the C2221 form|X-RAY DIFFRACTION|1.798|Bos taurus; Homo sapiens; SYNTHETIC CONSTRUCT|0|GENE REGULATION","6I7R|Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in the P43212 form|X-RAY DIFFRACTION|1.949|Homo sapiens; SYNTHETIC CONSTRUCT|0|GENE REGULATION","6R6H|Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome|ELECTRON MICROSCOPY|8.4|Homo sapiens|0|LIGASE","6R7F|Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome|ELECTRON MICROSCOPY|8.2|Homo sapiens|0|LIGASE","6SIS|Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|3.5|Homo sapiens|0|LIGASE","6ZHC|PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL|X-RAY DIFFRACTION|1.92|Homo sapiens|0|TRANSCRIPTION","7CJB|VHL recognizes hydroxyproline in RIPK1|X-RAY DIFFRACTION|2.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","7JTO|Crystal structure of Protac MS33 in complex with the WD repeat-containing protein 5 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|1.7|Homo sapiens|0|PROTEIN BINDING","7JTP|Crystal structure of Protac MS67 in complex with the WD repeat-containing protein 5 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.12|Homo sapiens|0|PROTEIN BINDING","7KHH|Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-11-oxoundecyl)-10-methyl-7-((methylsulfonyl)methyl)-11-oxo-3,4,10,11-tetrahydro-1H-1,4,10-triazadibenzo[cd,f]azulene-6-carboxamide)|X-RAY DIFFRACTION|2.281|Homo sapiens|0|PEPTIDE BINDING PROTEIN","7PI4|FAK Protac GSK215 in complex with FAK and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.24|Homo sapiens|0|TRANSFERASE","7Q2J|Quaternary Complex of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC Homer|X-RAY DIFFRACTION|2.5|Homo sapiens|0|STRUCTURAL PROTEIN","7S4E|Crystal Structure of ligand ACBi1 in complex with bromodomain of human Smarca2 and pVHL:ElonginC:ElonginB complex|X-RAY DIFFRACTION|2.25|Homo sapiens|0|GENE REGULATION","7Z6L|Crystal structure of PROTAC 5 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.24|Homo sapiens|0|LIGASE","7Z76|Crystal structure of compound 10 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|1.32|Homo sapiens|0|LIGASE","7Z77|Crystal structure of compound 6 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|1.97|Homo sapiens|0|LIGASE","7ZNT|CRYSTAL STRUCTURE OF AT7 IN COMPLEX WITH THE SECOND BROMODOMAIN OF HUMAN BRD4 AND PVHL:ELONGINC:ELONGINB|X-RAY DIFFRACTION|3|Homo sapiens|0|LIGASE","8BB2|Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #2)|X-RAY DIFFRACTION|2.05|Homo sapiens|0|LIGASE","8BB3|Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1)|X-RAY DIFFRACTION|1.8|Homo sapiens|0|LIGASE","8BB4|Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with C3 linker|X-RAY DIFFRACTION|2.8|Homo sapiens|0|LIGASE","8BB5|Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker|X-RAY DIFFRACTION|2.2|Homo sapiens|0|LIGASE","8BDI|VCB in complex with compound 32|X-RAY DIFFRACTION|2.108|Homo sapiens|0|LIGASE","8BDJ|VCB in complex with compound 30|X-RAY DIFFRACTION|2.02|Homo sapiens|0|LIGASE","8BDL|VCB in complex with compound 27|X-RAY DIFFRACTION|2.295|Homo sapiens|0|LIGASE","8BDM|VCB in complex with compound 26|X-RAY DIFFRACTION|2.021|Homo sapiens|0|LIGASE","8BDN|VCB in complex with compound 23|X-RAY DIFFRACTION|2.76|Homo sapiens|0|LIGASE","8BDO|VCB in complex with compound 21|X-RAY DIFFRACTION|2.8|Homo sapiens|0|LIGASE","8BDS|Ternary complex between VCB, BRD4-BD1 and PROTAC 48|X-RAY DIFFRACTION|1.72|Homo sapiens|0|LIGASE","8BDT|Ternary complex between VCB, BRD4-BD2 and PROTAC 51|X-RAY DIFFRACTION|2.7|Homo sapiens|0|LIGASE","8BDX|Ternary complex between VCB, BRD4-BD2 and PROTAC 48|X-RAY DIFFRACTION|2.93|Homo sapiens|0|LIGASE","8BEB|Ternary complex between VCB, BRD4-BD1 and PROTAC 49|X-RAY DIFFRACTION|3.18|Homo sapiens|0|LIGASE","8C13|Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48|X-RAY DIFFRACTION|2.3|Homo sapiens|0|LIGASE","8CQE|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(2-methyl-4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide (Compound 37)|X-RAY DIFFRACTION|2.85|Homo sapiens|0|LIGASE","8CQK|pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(2-methyl-4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide (Compound 30)|X-RAY DIFFRACTION|2.62|Homo sapiens|0|LIGASE","8CQL|pVHL:EloB:EloC in complex with (2S,4R)-N-((S)-1-(5-Fluoro-2-methoxy-4-(4-methylthiazol-5-yl)phenyl)ethyl)-1-((S)-2-(1-fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxamide (Compound 33)|X-RAY DIFFRACTION|2.38|Homo sapiens|0|LIGASE","8EI3|Crystal structure of VHL in complex with H313, a Helicon Polypeptide|X-RAY DIFFRACTION|3.49|Homo sapiens; SYNTHETIC CONSTRUCT|0|LIGASE","8EWV|DNA-encoded library (DEL)-enabled discovery of proximity inducing small molecules|X-RAY DIFFRACTION|3.4|Homo sapiens|0|APOPTOSIS","8FY0|E3:PROTAC:target ternary complex structure (VCB/753b/BCL-xL)|X-RAY DIFFRACTION|2.94|Homo sapiens|0|TRANSCRIPTION","8FY1|E3:PROTAC:target ternary complex structure (VCB/753b/BCL-2)|X-RAY DIFFRACTION|2.56|Homo sapiens|0|TRANSCRIPTION","8FY2|E3:PROTAC:target ternary complex structure (VCB/WH244/BCL-2)|X-RAY DIFFRACTION|2.98|Homo sapiens|0|TRANSCRIPTION","8G1P|Co-crystal structure of Compound 11 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.7|Homo sapiens|0|GENE REGULATION","8G1Q|Co-crystal structure of Compound 1 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|3.73|Homo sapiens|0|GENE REGULATION","8P0F|Crystal structure of the VCB complex with compound 1.|X-RAY DIFFRACTION|1.98|Homo sapiens|0|LIGASE","8PC2|SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC|X-RAY DIFFRACTION|2.8|Homo sapiens|0|ISOMERASE","8QJR|BRG1 bromodomain in complex with VBC via compound 17|X-RAY DIFFRACTION|3.17|Homo sapiens|0|GENE REGULATION","8QJS|VHL/Elongin B/Elongin C complex with compound 155|X-RAY DIFFRACTION|3.191|Homo sapiens|0|LIGASE","8QU8|PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1|ELECTRON MICROSCOPY|3.5|Homo sapiens|0|TRANSFERASE","8QVU|Crystal Structure of ligand ACBI3 in complex with KRAS G12D C118S GDP and pVHL:ElonginC:ElonginB complex|X-RAY DIFFRACTION|2.24|Homo sapiens|0|GENE REGULATION","8QW6|Crystal Structure of compound 3 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.2|Homo sapiens|0|ONCOPROTEIN","8QW7|Crystal Structure of compound 4 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB|X-RAY DIFFRACTION|2.36|Homo sapiens|0|ONCOPROTEIN"]}]}